Klotho Neurosciences Inc

KLTO14 Dec 2024
Healthcare
$0.41
-0.03 (-2.56%)
Lowest Today
$0.41
Highest Today
$0.44
Today’s Open
$0.41
Prev. Close
$0.44
52 Week High
$13.1
52 Week Low
$0.26
To Invest in Klotho Neurosciences Inc

Klotho Neurosciences Inc

Healthcare
KLTO14 Dec 2024
-0.03 (-2.56%)
1M
3M
6M
1Y
5Y
Low
$0.41
Day’s Range
High
$0.44
0.41
52 Week Low
$0.26
52-Week Range
52 Week High
$13.1
0.26
1 Day
-
1 Week
-7.41%
1 month return
+63.83%
3 month return
-39.72%
6 month return
-38.98%
1 Year return
-
3 Years return
-
5 Years return
-
10 Years return
-
Fundamentals
Market Cap
17.65 mln
PB Ratio
43.36
PE Ratio
0
Enterprise Value
20.7 mln
Total Assets
2.54 mln
Volume

Fund house & investment objective

Company Information
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Organisation
Klotho Neurosciences Inc
Employees
0
Industry
Biotechnology
CEO
Dr. Joseph  Sinkule Pharm.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities